Exponent (EXPO) PT Raised to $75 at Cantor Fitzgerald Following 2Q Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Pre-Open Stock Movers 07/19: (AEZS) (VRTX) (SNI) Higher; (DRYS) (NTRS) (HDP) Lower (more...)
July 19, 2017 9:26 AM EDTToday's Pre-Open Stock Movers
Aeterna Zentaris Inc. (NASDAQ: AEZS) 48% HIGHER; announced that it has been notified by the U.S. Food and Drug Administration (FDA), that the Companys New Drug Application (NDA) seeking approval of Macrilen (macimorelin) for the evaluation of growth hormone deficiency in adults (AGHD) has been accepted as a complete response to the FDAs November 5, 2014 Complete Response Letter and granted a PDUFA date of December 30, 2017.
DryShips Inc. (NASDAQ: DRYS) 30.8% LOWER; announced today... More
After-Hours Stock Movers 07/18: (AEZS) (VRTX) (EXPO) Higher; (DRYS) (HDP) (IBM) (CSX) (UAL) Lower (more...)
July 18, 2017 6:06 PM EDTToday's After-Hours Movers
Aeterna Zentaris Inc. (NASDAQ: AEZS) 31.4% HIGHER; announced that it has been notified by the U.S. Food and Drug Administration (FDA), that the Companys New Drug Application (NDA) seeking approval of Macrilen (macimorelin) for the evaluation of growth hormone deficiency in adults (AGHD) has been accepted as a complete response to the FDAs November 5, 2014 Complete Response Letter and granted a PDUFA date of December 30, 2017.
DryShips Inc. (NASDAQ: DRYS) 26.9% LOWER; announced today that its Board... More
UPDATE: Exponent, Inc. (EXPO) Tops Q2 EPS by 10c
July 18, 2017 4:06 PM EDT(Updated - July 18, 2017 4:09 PM EDT)
(updated to add guidance outlook)
Exponent, Inc. (NASDAQ: EXPO) reported Q2 EPS of $0.51, $0.10 better than the analyst estimate of $0.41. Revenue for the quarter came in at $87.84 million versus the consensus estimate of $81.21... More
Exponent, Inc. (EXPO) Declares $0.21 Quarterly Dividend; 1.4% Yield
July 18, 2017 4:05 PM EDTExponent, Inc. (NASDAQ: EXPO) declared a quarterly dividend of $0.21 per share, or $0.84 annualized.
The dividend will be payable on September 22, 2017, to stockholders of record on September 1, 2017, with an ex-dividend date of August 30, 2017.
The annual yield on the dividend is 1.4 percent.
For a... More
